Quick Answer
ASSEMBLY BIOSCIENCES, INC. reported Stockholders Equity of $206.75 million for the year ending 2025.
- ASSEMBLY BIOSCIENCES, INC. showed an increase of +519.8% in Stockholders Equity from 2024 to 2025.
- This data is from ASSEMBLY BIOSCIENCES, INC.'s annual report (Form 10-K), filed with the SEC on March 19, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2011: $34.53 million | Q1 2012: $27.54 million | Q2 2012: $25.62 million | Q3 2012: $21.00 million | Q1 2013: $35.13 million | Q2 2013: $31.09 million | Q3 2013: $30.05 million | Q1 2014: $22.44 million | Q2 2014: $20.29 million | Q3 2014: $47.20 million | Q1 2015: $124.62 million | Q2 2015: $130.87 million | Q3 2015: $125.40 million | Q1 2016: $109.28 million | Q2 2016: $100.56 million | Q3 2016: $90.04 million | Q1 2017: $67.89 million | Q2 2017: $56.54 million | Q3 2017: $47.13 million | Q1 2018: $102.38 million | Q2 2018: $89.10 million | Q3 2018: $229.43 million | Q1 2019: $190.40 million | Q2 2019: $174.71 million | Q3 2019: $156.49 million | Q1 2020: $251.77 million | Q2 2020: $267.12 million | Q3 2020: $270.55 million | Q1 2021: $247.24 million | Q2 2021: $231.79 million | Q3 2021: $224.65 million | Q1 2022: $146.79 million | Q2 2022: $123.98 million | Q3 2022: $102.40 million | Q1 2023: $70.33 million | Q2 2023: $54.95 million | Q3 2023: $41.71 million | Q1 2024: $32.60 million | Q2 2024: $34.68 million | Q3 2024: $26.00 million | Q1 2025: $27.13 million | Q2 2025: $18.10 million | Q3 2025: $182.70 million.
- Over the full 16 years of available data (2010 to 2025), ASSEMBLY BIOSCIENCES, INC.'s Stockholders Equity has grown by 1,678.3%.
- Historical annual values: Fiscal year 2025: $206.75 million | Fiscal year 2024: $33.36 million | Fiscal year 2023: $41.10 million | Fiscal year 2022: $82.66 million | Fiscal year 2021: $168.93 million | Fiscal year 2020: $240.58 million | Fiscal year 2019: $273.22 million | Fiscal year 2018: $210.65 million | Fiscal year 2017: $113.12 million | Fiscal year 2016: $79.88 million | Fiscal year 2015: $118.74 million | Fiscal year 2014: $58.57 million | Fiscal year 2013: $24.49 million | Fiscal year 2012: $17.81 million | Fiscal year 2011: $34.53 million | Fiscal year 2010: $11.63 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: